CN Patent

CN104817554A — 一类葡萄糖苷衍生物及其药物组合物

Assigned to Zhenjiang New Element Pharmaceutical Technology Co Ltd · Expires 2015-08-05 · 11y expired

What this patent protects

一类葡萄糖苷衍生物及其药物组合物，本发明公开了一类通式(I)所示的化合物、其药学上可接受的盐、其易水解的前药酯或其异构体，以及包含这类化合物的药物组合物作为钠-葡萄糖协同转运蛋白2抑制剂，用于治疗或延缓糖尿病、糖尿病性视网膜病、糖尿病性神经病、糖尿病性肾病、胰岛素抗性等相关疾病。

USPTO Abstract

一类葡萄糖苷衍生物及其药物组合物，本发明公开了一类通式(I)所示的化合物、其药学上可接受的盐、其易水解的前药酯或其异构体，以及包含这类化合物的药物组合物作为钠-葡萄糖协同转运蛋白2抑制剂，用于治疗或延缓糖尿病、糖尿病性视网膜病、糖尿病性神经病、糖尿病性肾病、胰岛素抗性等相关疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN104817554A
Jurisdiction
CN
Classification
—
Expires
2015-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Zhenjiang New Element Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.